SLU-PP-332 is a cutting-edge, investigational peptide shown to activate the same gene pathways as exercise without physical exertion
Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S
Diet, training, baseline metabolic health, and dosage all influence the timeline
It primarily works by activating AMPK, a master regulator of energy balance and metabolism
FKBP8 recruits LC3A to mediate Parkin-independent mitophagy
This makes it a powerful tool for individuals struggling with metabolic syndrome, insulin resistance, or age-related metabolic decline